Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
mAb, monoclonal antibody
Currently, a phase II clinical trial investigating the efficacy of dupilumab for the treatment of AA (NCT03359356) has been completed
& Patrick, J
Clinician-led dose adjustments of existing diabetes medicines may be required
Molybdenum: Fact Sheet for Health Professionals
Consider these research findings: Biofilm formation: Bacterial biofilms can form in chronic nummular lesions, contributing to treatment resistance [3] Altered drug penetration: The thick, scaly (hyperkeratotic) nature of chronic lesions can reduce the absorption of topical medications [13] Neurogenic inflammation: The density of nerve fibers containing Substance P, a neuropeptide involved in inflammation and itching, is significantly increased in nummular eczema lesions [14] Most frustrating is the rebound phenomenon that can occur after discontinuing topical steroids, which can lead to a dependency cycle [15]
US$ 20.74
US$ 21.74
US$ 22.03
US$ 21.55
US$ 22.02
US$ 28.83
US$ 26.54
